| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 04/18/2002 | WO2001079452A3 Tolerance-inducing thy-marrow composite tissue construct and organ |
| 04/18/2002 | WO2001072777A3 Human transcription factors |
| 04/18/2002 | WO2001066699A3 P27 and p21 in gene therapies |
| 04/18/2002 | WO2001066595A3 Human fgf-23 gene and gene expression products |
| 04/18/2002 | WO2001064876A3 Human schizophrenia gene |
| 04/18/2002 | WO2001064833A3 Ex vivo generation of functional leukemia cells in a three-dimensional bioreactor |
| 04/18/2002 | WO2001061007A9 Fibroblast growth factor-23 molecules and uses thereof |
| 04/18/2002 | WO2001058916A3 Antibodies to ccr5 |
| 04/18/2002 | WO2001051520A3 Nogo receptor-mediated blockade of axonal growth |
| 04/18/2002 | WO2001049824A3 Cell growth substrate hydrogels |
| 04/18/2002 | WO2001040271A3 Cancer associated antigens and uses therefor |
| 04/18/2002 | WO2001027324A3 Converting diploidy to haploidy for genetic diagnosis |
| 04/18/2002 | WO2001025437A3 Growth factor polypeptides and nucleic acids encoding same |
| 04/18/2002 | WO2000073482A9 Use of recombinant gene delivery vectors for treating or preventing lysosomal storage disorders |
| 04/18/2002 | WO2000073417A9 In vitro cell culture device including cartilage and methods of using the same |
| 04/18/2002 | WO2000072887A9 A novel packaging cell line for the rescue, production and titration of high-capacity adenovirus amplicon vectors |
| 04/18/2002 | WO2000071752A9 Assay for the detection of paclitaxel resistant cells in human tumors |
| 04/18/2002 | WO2000068411A9 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
| 04/18/2002 | WO2000068387A9 Nucleic acids and proteins with interferon-beta activity |
| 04/18/2002 | WO2000068385A9 Novel nucleic acids and proteins with growth hormone activity |
| 04/18/2002 | US20020046416 Plant proteins |
| 04/18/2002 | US20020046412 Use for finding active compounds for crop protection |
| 04/18/2002 | US20020045907 Microstructures for treating and conditioning skin |
| 04/18/2002 | US20020045859 Microstructures for delivering a composition cutaneously to skin |
| 04/18/2002 | US20020045737 Enterococcus faecalis polynucleotides and polypeptides |
| 04/18/2002 | US20020045734 Geneticaly engineered polypeptide for use drug delivery tools |
| 04/18/2002 | US20020045588 Telomerase Reverse Transcriptase (TERT); treatment of cancer; modulating apoptosis |
| 04/18/2002 | US20020045577 Human schizophrenia gene |
| 04/18/2002 | US20020045264 Expression vectors for use in gene therapy |
| 04/18/2002 | US20020045262 Human liver cell line |
| 04/18/2002 | US20020045261 Genetically engineered cells for use in the treatment of tumors; antitumor agents |
| 04/18/2002 | US20020045260 Recovering preferential progenitor cells; provide mixture of progenitor cells, incubate in culture apparatus, recover and propagate cells |
| 04/18/2002 | US20020045259 Human embryonic stem cells derived from frozen-thawed embryo |
| 04/18/2002 | US20020045258 Methods to prepare and use epidermal stem cells |
| 04/18/2002 | US20020045257 Forming embryonic germ cells useful as model for studying imprinting; mate mammals, obtain embryo, dissociate embryonic cells, culturing the dissociated cells |
| 04/18/2002 | US20020045256 Method for enhancing primordial germ cell number |
| 04/18/2002 | US20020045255 Method of making glycoprotein exhibiting erythropoiesis regulating activity and glycoprotein produced by this method |
| 04/18/2002 | US20020045254 Established cells |
| 04/18/2002 | US20020045253 Isolation of primordial germ cells, culturing these cells to produce primordial germ cell-derived cell lines, methods for transforming both the primordial germ cells and the cultured cell lines |
| 04/18/2002 | US20020045252 Activating cells associated with preventing immune response; obtain cells, incubate with immunomodulator, monitor cell for immune response |
| 04/18/2002 | US20020045251 Generating mammalian nervous system stem cells; obtain nervous system tissue, incubate with mitogen, monitor cells for differentiation into preferential tissues of nervous system |
| 04/18/2002 | US20020045247 Expression vector for use in human and primate gene therapy |
| 04/18/2002 | US20020045241 T cells specific for kidney carcinoma |
| 04/18/2002 | US20020045229 Nucleotide sequences coding membrane protein for use inthe treatment of epilepsey, arrhythmia, and pain in humans |
| 04/18/2002 | US20020045219 Generating hybrid cell expresses telomerase; obtain cells, fuse, transform cells, monitor cell for expression of telomerase |
| 04/18/2002 | US20020045217 Novel tumor suppressor encoding nucleic acid, PTX1, and methods of use thereof |
| 04/18/2002 | US20020045213 IL-17 receptor like molecules and uses thereof |
| 04/18/2002 | US20020045211 Plasmid for use in the generation of genetically engineered amino acid sequences |
| 04/18/2002 | US20020045206 Contacting the cells with a trophic amount of a ptc therapeutic for promoting survival of substantia nigra neuronal cells |
| 04/18/2002 | US20020045202 Enzymatic polypeptide for use in diagnosis, prevention and treatment of inflammatory defects, cancer, diabetes |
| 04/18/2002 | US20020045201 Sreening drugs for use in treatment of nervous system disorders; obtain protein sample, mix with modulator, monitor complex formation, compare to control, adjustment in concentration of preferential complex indicates modulator |
| 04/18/2002 | US20020045196 Methods of isolating trophoblast cells from maternal blood |
| 04/18/2002 | US20020045167 Used for detecting incomplete deprotection of a synthetic oligonucleotide by immunoassay |
| 04/18/2002 | US20020045166 Peptides; for use as tools in gene therapy |
| 04/18/2002 | US20020045164 Reagents and methods useful for detecting diseases of the lung |
| 04/18/2002 | US20020045158 Cells for drug discovery |
| 04/18/2002 | US20020045156 Microinjection of cryoprotectants for preservation of cells |
| 04/18/2002 | US20020044952 Attenuated live neospora vaccine |
| 04/18/2002 | US20020044950 Recombinant toxin fragments |
| 04/18/2002 | US20020044946 12-25 kDa bacterial proteins and their 116-58 kDa polymers useful in anti-tumor vaccines |
| 04/18/2002 | US20020044937 Where the protein binds to T-cell cell surface protein, and that complex with nucleic acids, for transporting nucleic acids into human or animal cells which express the T-cell surface protein; antisense therapy, HIV therapy |
| 04/18/2002 | US20020044925 Myoblast transfer therapy for relieving pain and for treating behavioral and perceptive abnormalities |
| 04/18/2002 | US20020044923 Modulating immune responses using antigen presenting human mesenchymal stem cells to induce specific T cell anergy |
| 04/18/2002 | DE10053014A1 In vitro production of substitute patch tissue, for reconstruction of cardio vascular structures, comprises cell culture-tissue structure in bioreactor subjected to shifting pressures and movements |
| 04/18/2002 | DE10044384A1 Wirtszellen zur Verpackung von rekombinantem Adeno-assoziiertem Virus (rAAV), Verfahren zu ihrer Herstellung und deren Verwendung Host cells for the packaging of recombinant adeno-associated virus (rAAV), processes for their preparation and their use |
| 04/18/2002 | CA2811096A1 Enhanced selection of genetically modified pine embryogenic tissue |
| 04/18/2002 | CA2785941A1 Antibody composition-producing cell |
| 04/18/2002 | CA2705037A1 Method for pine cell tissue culture on support membrane |
| 04/18/2002 | CA2425835A1 Methods and compositions for nucleic acid delivery |
| 04/18/2002 | CA2425815A1 Treatment of t cell disorders |
| 04/18/2002 | CA2425809A1 Humanized anti-lt-.beta.-r antibodies |
| 04/18/2002 | CA2425767A1 Lipocalins |
| 04/18/2002 | CA2425671A1 Human ect2 and methods of use |
| 04/18/2002 | CA2425569A1 Methods of diagnosis of prostate cancer, compositions and methods of screening for modulators of prostate cancer |
| 04/18/2002 | CA2425318A1 Far red shifted fluorescent proteins |
| 04/18/2002 | CA2425302A1 Novel polypeptides homologous to thymosin, ephrin a, receptors, and fibromodulin, and polynucleotides encoding same |
| 04/18/2002 | CA2425298A1 Isolated human nuclear hormone receptors, nucleic acid molecules encoding human nuclear hormone receptors, and uses thereof |
| 04/18/2002 | CA2425001A1 Novel serine protease genes related to dppiv |
| 04/18/2002 | CA2424983A1 Nucleic acid molecules and polypeptides for immune modulation |
| 04/18/2002 | CA2424967A1 Complexes for transferring nucleic acids into cells |
| 04/18/2002 | CA2424821A1 Gene encoding a human g-protein coupled receptor and its use |
| 04/18/2002 | CA2424433A1 Bvh-a2 and bvh-a3 antigens of group b streptococcus |
| 04/18/2002 | CA2424317A1 Mammalian two-hybrid system for screening for modulators of the accumulation of metabolic products |
| 04/18/2002 | CA2422934A1 Antisense oligonucleotides directed toward mammalian vegf receptor genes and uses thereof |
| 04/17/2002 | EP1197567A2 Characterisation of gene function using double stranded RNA inhibition |
| 04/17/2002 | EP1197558A2 Theobromine synthase polypeptide of coffee plant and the gene encoding said polypeptide |
| 04/17/2002 | EP1197550A2 Methods and compositions for diagnosing and treating disorders involving angiogenesis |
| 04/17/2002 | EP1197549A2 Method for cloning and producing the MseI restriction endonuclease |
| 04/17/2002 | EP1197496A1 Novel peptides |
| 04/17/2002 | EP1197229A1 Method of inactivating microorganisms |
| 04/17/2002 | EP1197221A1 Preparations stabilized over long time |
| 04/17/2002 | EP1197139A1 Construction of rice tolerant to iron deficiency |
| 04/17/2002 | EP1196779A1 Determining antibodies to ny-eso-1 in cancer patients |
| 04/17/2002 | EP1196774A2 Miniaturized cell array methods and apparatus for cell-based screening |
| 04/17/2002 | EP1196635A2 Cell death related drug targets in yeast and fungi |
| 04/17/2002 | EP1196616A2 Replication-competent anti-cancer vectors |
| 04/17/2002 | EP1196614A1 Plant multi-gene expression constructs |
| 04/17/2002 | EP1196612A2 Dna binding protein and sequence as insulators having specific enhancer blocking activity for regulation of gene expression |
| 04/17/2002 | EP1196608A2 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 04/17/2002 | EP1196600A1 Drosophila recombination-associated protein and methods for use |